LXRX
Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities
Monday, March 11, 2024 BiopharmaWatch Research 1 min read Key Takeaway: Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities
Price reaction · baseline $2.17 (2024-03-08 close) · 1 other LXRX headline(s) in the window, move may be shared
day 0 close · peak
+29.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus
Full Press Release Details
Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities.